1. Home
  2. PRQR vs CRML Comparison

PRQR vs CRML Comparison

Compare PRQR & CRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • CRML
  • Stock Information
  • Founded
  • PRQR 2012
  • CRML N/A
  • Country
  • PRQR Netherlands
  • CRML United States
  • Employees
  • PRQR N/A
  • CRML N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • CRML
  • Sector
  • PRQR Health Care
  • CRML
  • Exchange
  • PRQR Nasdaq
  • CRML NYSE
  • Market Cap
  • PRQR 179.1M
  • CRML 147.9M
  • IPO Year
  • PRQR 2014
  • CRML N/A
  • Fundamental
  • Price
  • PRQR $1.94
  • CRML $1.61
  • Analyst Decision
  • PRQR Strong Buy
  • CRML
  • Analyst Count
  • PRQR 7
  • CRML 0
  • Target Price
  • PRQR $9.00
  • CRML N/A
  • AVG Volume (30 Days)
  • PRQR 302.0K
  • CRML 1.8M
  • Earning Date
  • PRQR 08-07-2025
  • CRML 02-01-2025
  • Dividend Yield
  • PRQR N/A
  • CRML N/A
  • EPS Growth
  • PRQR N/A
  • CRML N/A
  • EPS
  • PRQR N/A
  • CRML N/A
  • Revenue
  • PRQR $21,212,711.00
  • CRML $476,979.00
  • Revenue This Year
  • PRQR $2.87
  • CRML N/A
  • Revenue Next Year
  • PRQR N/A
  • CRML N/A
  • P/E Ratio
  • PRQR N/A
  • CRML N/A
  • Revenue Growth
  • PRQR 85.91
  • CRML 326.80
  • 52 Week Low
  • PRQR $1.07
  • CRML $1.23
  • 52 Week High
  • PRQR $4.62
  • CRML $12.00
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 63.06
  • CRML 54.72
  • Support Level
  • PRQR $1.77
  • CRML $1.39
  • Resistance Level
  • PRQR $1.96
  • CRML $1.52
  • Average True Range (ATR)
  • PRQR 0.10
  • CRML 0.11
  • MACD
  • PRQR 0.01
  • CRML 0.03
  • Stochastic Oscillator
  • PRQR 80.78
  • CRML 95.08

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About CRML CRITICAL METALS CORPORATION

Critical Metals Corp is engaged in lithium exploration in Austria. It is focused on the development of its wholly-owned Wolfsberg Lithium Project (the Wolfsberg Project) located in Carinthia, Austria.

Share on Social Networks: